For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab31324? Please let us know so that we can cite the reference in this datasheet.
ab31324 has been referenced in 1 publication.
- Chase A et al. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. Haematologica 98:103-6 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"